SCHEMBL21532553

SCHEMBL21532553

c1ccc(-c2nnc(-c3ccc4c(c3)c3ccccc3n4-c3ccccc3-c3ccccc3-n3c4ccccc4c4ccc5c6ccccc6oc5c43)n2-c2ccccc2)cc1

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
TSHR P16473 2/20 0.34
HSD17B10 Q99714 2/20 0.34
AVPR1A P37288 1/20 0.34
ALOX5 P09917 1/20 0.33
HPGD P15428 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PTGER4 P35408 1/20 0.33
PRKDC P78527 1/20 0.32
ATM Q13315 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
AKT1 P31749 3/20 0.31
METAP2 P50579 1/20 0.31
MEN1 O00255 1/20 0.30
POLB P06746 1/20 0.30
BRCA1 P38398 1/20 0.30
KMT2A Q03164 1/20 0.30
OPRD1 P41143 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21532534 0.96 AVPR1A (0.35) KDM4EALDH1A1TSHRHSD17B10AVPR1A
SCHEMBL21532679 0.95 AVPR1A (0.36) KDM4EALDH1A1TSHRHSD17B10AVPR1A
SCHEMBL21532532 0.94 ALOX5 (0.35) KDM4EALDH1A1TSHRHSD17B10AVPR1A
SCHEMBL21532540 0.92 ALDH1A1 (0.34) KDM4EALDH1A1TSHRHSD17B10ALOX5
SCHEMBL21532465 0.92 ALDH1A1 (0.34) KDM4EALDH1A1TSHRHSD17B10AVPR1A
SCHEMBL21532680 0.91 AVPR1A (0.37) KDM4EALDH1A1TSHRHSD17B10AVPR1A
SCHEMBL21532544 0.90 KDM4E (0.36) KDM4EALDH1A1TSHRHSD17B10AVPR1A
SCHEMBL21532537 0.90 ALOX5 (0.36) KDM4EALDH1A1TSHRHSD17B10AVPR1A
SCHEMBL21532539 0.89 ALDH1A1 (0.35) KDM4EALDH1A1TSHRHSD17B10ALOX5
SCHEMBL21532716 0.89 KDM4E (0.35) KDM4EALDH1A1TSHRHSD17B10AVPR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11145825-B2 Condensed cyclic compound and organic light-emitting device including i he same SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-10-12 US disclosed
US-20190334095-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11145825-B2 Condensed cyclic compound and organic light-emitting device including i he same CRY1, CCNT1, CCNA1 KDM4E 4144/4885ALDH1A1 158/4885TSHR 3802/4885
US-20190334095-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNT1, ARL1 KDM4E 3893/4885ALDH1A1 283/4885TSHR 3504/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.